SPD-473 citrate

CAS No. 161190-26-7

SPD-473 citrate( —— )

Catalog No. M33235 CAS No. 161190-26-7

SPD-473 citrate (BTS 74398 citrate) is a dopamine reuptake inhibitor, a norepinephrine transporter protein (NET) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 352 In Stock
10MG 495 In Stock
25MG 791 In Stock
50MG 1042 In Stock
100MG 1404 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SPD-473 citrate
  • Note
    Research use only, not for human use.
  • Brief Description
    SPD-473 citrate (BTS 74398 citrate) is a dopamine reuptake inhibitor, a norepinephrine transporter protein (NET) inhibitor.
  • Description
    SPD-473 citrate is a serotonin/dopamine/norepinephrine reuptake inhibitior.
  • In Vitro
    SPD-473 inhibits the synaptic reuptake of dopamine, serotonin and noradrenaline, making it a triple reuptake inhibitor potentially for the treatment of Parkinson's Disease.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine Receptor | 5-HT Receptor | Norepinephrine
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    161190-26-7
  • Formula Weight
    552.47
  • Molecular Formula
    C23H31Cl2NO8S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)CC(O)(C(=O)O)CC(=O)O.O=C(CSCCCN(C)C)C1(C2=CC=C(Cl)C(Cl)=C2)CCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pentiapine

    Pentiapine is a novel inhibitor of dopamine release.

  • Dehydroevodiamine

    Dehydroevodiamine, a constituent of Evodia rutaecarpa, has various biological effects such as hypotensive, negative chronotropic, ion channel depressant, inhibition of nitric oxide production and cerebral blood flow enhancing activities.

  • JNJ-37822681

    JNJ-37822681 is a novel, highly selective dopamine D? receptor antagonist characterized by a rapid dissociation rate from the dopamine D? receptor.